Form 4: Bicycle Therapeutics Executive Sells Shares to Cover Tax Obligations

Nigel Crockett, Chief Business Officer of Bicycle Therapeutics, sold 955 ordinary shares to cover tax withholding obligations related to the vesting and settlement of Restricted Stock Units (RSUs).

Summary

• On April 3, 2024, Nigel Crockett, the Chief Business Officer of Bicycle Therapeutics plc, sold 955 ordinary shares of the company.
• The sale was executed to cover statutory tax withholding obligations associated with the vesting and settlement of RSUs.
• The shares were sold at a weighted average price of $23.81, with individual transactions ranging from $23.75 to $24.05.
• Following the transaction, Crockett still beneficially owns 47,761 ordinary shares of Bicycle Therapeutics plc.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (sale of shares to cover taxes). It doesn't inherently indicate positive or negative sentiment regarding the company's performance.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among company executives and do not necessarily indicate a negative outlook on the company's future.

Stakeholder Impact

• The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to have a significant impact due to the small number of shares involved and the routine nature of the transaction.

Key Dates